Snowball logo
logo
3386_logo

Cosmo Bio Co Ltd

3386 TSE
¥1,236.00+¥20.00  (1.64%)
Estimate
P/E
20.9
EPS
59.24
Beta
0.17
Growth
Revenue, YoY
11.87%
Net income, YoY
45.95%
Dividends
Dividend yield
4.05%
Annual payout
¥50.00
Next ex. div date
December 29, 26
Payout
103.57%
Div.growth, 5y
22.67%
Div.rating
About the company
Ticker
3386
ISIN
JP3298700000
Country
Japan
Sector (GICS)
Healthcare
Cosmo Bio Company,Limited, together with its subsidiaries, operates as a life science trading company worldwide. It is involved in the import, export, manufacture, marketing, sales, and customer support of life science research bio tools, such as reagents, kits, instruments, and software. The company also distributes antibodies, antigens, biologically active substances, enzymes, substrates, peptides, amino acids, chemicals, carbohydrates, lipids, virus components, and bacteria, as well as detection reagents, cell and tissue culture systems, and gene analysis systems; and research instruments, including electrophoresis apparatuses, cell culture labware, gene manipulation systems, and data analysis software. In addition, it provides drug discovery and custom research services; clinical diagnostics; cell and DNA, and protein engineering solutions; disposable items and general labware; and bioactive substances; consigned services, such as intestinal flora analysis, tear fluid analysis, and cell assays services; and custom peptide synthesis and antibody production services. Further, the company manufactures and sells cell/cell culture products comprising adipose tissue, bone, cartilage, tooth, pancreas, liver function, cardiovascular, immune, mesenchymal stem cells, feeder cells, tumor cell lines, macrophage-related, and coating reagents; measurement and staining kits, detection/purification kits related to neurodementia, macrophage/immune, exosome, and anti-saccharification/anti-aging; and biotechnology research equipment, such as constant-temperature transport containers, aluminum block mat heat insulation devices, and dew condensation prevention glass plate. It serves universities, public research institutes, and companies engaged in biological science. Cosmo Bio Company, Limited was founded in 1978 and is headquartered in Koto, Japan.

Frequently asked questions

What sector does Cosmo Bio Co Ltd (3386) operate in?

Cosmo Bio Co Ltd belongs to the Healthcare sector and operates in the Diagnostics & Research industry.

What is Cosmo Bio Co Ltd (3386) current stock price?

As of the latest data, Cosmo Bio Co Ltd stock price is ¥1,236, with a previous close of ¥1,216. Cosmo Bio Co Ltd gained ¥20 in the last trading session, representing a 1.64% increase.

What is Cosmo Bio Co Ltd (3386) current market capitalization?

Cosmo Bio Co Ltd market cap is approximately 7.01 billion.

What is Cosmo Bio Co Ltd (3386) Earnings Per Share (EPS)?

The trailing EPS is ¥59.

What is Cosmo Bio Co Ltd (3386) Price-to-Earnings (P/E) ratio?

Cosmo Bio Co Ltd current P/E ratio is 20.86.

What is Cosmo Bio Co Ltd (3386) EBITDA?

Cosmo Bio Co Ltd EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 56.00 million.

Does Cosmo Bio Co Ltd (3386) pay dividends?

Yes. Cosmo Bio Co Ltd pays semiannual dividends with an annualized yield of 4.05% and an estimated annual payout of ¥50 per share.

When is the next ex-dividend date for Cosmo Bio Co Ltd (3386)?

The next ex-dividend date is scheduled for December 29, 2026.

What is Cosmo Bio Co Ltd (3386) beta (volatility) score?

Cosmo Bio Co Ltd has a beta of 0.170, indicating lower volatility than the overall market.